Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 16232197)

1.

Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung.

Peng WX, Shibata T, Katoh H, Kokubu A, Matsuno Y, Asamura H, Tsuchiya R, Kanai Y, Hosoda F, Sakiyama T, Ohki M, Imoto I, Inazawa J, Hirohashi S.

Cancer Sci. 2005 Oct;96(10):661-7.

PMID:
16232197
2.

Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.

Shibata T, Uryu S, Kokubu A, Hosoda F, Ohki M, Sakiyama T, Matsuno Y, Tsuchiya R, Kanai Y, Kondo T, Imoto I, Inazawa J, Hirohashi S.

Clin Cancer Res. 2005 Sep 1;11(17):6177-85.

3.

Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.

Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR.

Genes Chromosomes Cancer. 1997 Dec;20(4):320-8.

PMID:
9408747
4.

Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.

Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y, Kosuge T, Fukayama M, Kondo T, Sakamoto M, Hosoda F, Ohki M, Imoto I, Inazawa J, Hirohashi S.

J Hepatol. 2005 Nov;43(5):863-74. Epub 2005 Jul 5.

PMID:
16139920
5.

Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.

Ullmann R, Schwendel A, Klemen H, Wolf G, Petersen I, Popper HH.

Hum Pathol. 1998 Oct;29(10):1145-9.

PMID:
9781656
6.

Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.

D'Adda T, Bottarelli L, Azzoni C, Pizzi S, Bongiovanni M, Papotti M, Pelosi G, Maisonneuve P, Antonetti T, Rindi G, Bordi C.

Mod Pathol. 2005 Jun;18(6):795-805.

7.

Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.

Olejniczak ET, Van Sant C, Anderson MG, Wang G, Tahir SK, Sauter G, Lesniewski R, Semizarov D.

Mol Cancer Res. 2007 Apr;5(4):331-9.

8.

High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.

Garnis C, Lockwood WW, Vucic E, Ge Y, Girard L, Minna JD, Gazdar AF, Lam S, MacAulay C, Lam WL.

Int J Cancer. 2006 Mar 15;118(6):1556-64.

PMID:
16187286
9.

Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.

Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, Meuwissen SG, Albertson D, Meijer GA.

Cell Oncol. 2004;26(5-6):307-17.

PMID:
15623941
10.

Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome.

Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J, Hirohashi S.

Cancer Sci. 2007 Mar;98(3):392-400. Epub 2007 Jan 12.

PMID:
17233815
11.

Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.

Heidenblad M, Schoenmakers EF, Jonson T, Gorunova L, Veltman JA, van Kessel AG, Höglund M.

Cancer Res. 2004 May 1;64(9):3052-9.

12.

High-grade neuroendocrine carcinomas display unique cytogenetic aberrations.

Welborn J, Jenks H, Taplett J, Walling P.

Cancer Genet Cytogenet. 2004 Nov;155(1):33-41.

PMID:
15527900
13.

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7012-22.

14.

Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.

Kang JU, Koo SH, Kwon KC, Park JW, Kim JM.

Cancer Genet Cytogenet. 2008 Apr 1;182(1):1-11. doi: 10.1016/j.cancergencyto.2007.12.004.

PMID:
18328944
15.

Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.

Roman E, Meza-Zepeda LA, Kresse SH, Myklebost O, Vasstrand EN, Ibrahim SO.

Oncol Rep. 2008 Oct;20(4):825-43.

PMID:
18813824
16.

Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.

Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K, Hirohashi S, Inazawa J, Imoto I.

Cancer Sci. 2008 May;99(5):986-94. doi: 10.1111/j.1349-7006.2008.00779.x.

PMID:
18380791
17.

Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.

Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM.

Cancer Res. 2003 Jun 1;63(11):2872-80.

18.

Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers.

Kim TM, Yim SH, Lee JS, Kwon MS, Ryu JW, Kang HM, Fiegler H, Carter NP, Chung YJ.

Clin Cancer Res. 2005 Dec 1;11(23):8235-42.

19.

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.

Taniguchi T, Karnan S, Fukui T, Yokoyama T, Tagawa H, Yokoi K, Ueda Y, Mitsudomi T, Horio Y, Hida T, Yatabe Y, Seto M, Sekido Y.

Cancer Sci. 2007 Mar;98(3):438-46.

PMID:
17270034
20.

[CGH findings in neuroendocrine tumours of the lung].

Johnen G, Krismann M, Jaworska M, Müller KM.

Pathologe. 2003 Jul;24(4):303-7. Epub 2003 May 15. German.

PMID:
14513278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk